Menu
Orthofix Medical Inc. is a global medical device and biologics company with a spine and extremities focus. The Company's mission is to deliver innovative, quality-driven solutions as it partners with health care professionals to improve patients' lives. Headquartered in Lewisville, Texas, Orthofix's spine and orthopedic extremities products are distributed in more than 70 countries via the Company's sales representatives and distributors.
New York, New York--(Newsfile Corp. - August 30, 2024) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Orthofix Medical Inc. (NASDAQ: OFIX) between October 11, 2022 and September 12, 2023, both dates inclusive (the "Class Period"), of the important October 21, 2024 lead plaintiff deadline. SO WHAT: If you purchased Orthofix common stock during Jetzt den vollständigen Artikel lesen
We came across a bullish thesis on Orthofix Medical Inc (OFIX) on ValueInvestorsClub by aa123. In this article we will summarize the bulls’ thesis on OFIX. Orthofix Medical shares were trading at $14.64 when this thesis was published, vs. closing price of $17.37 on Aug 13. Orthofix (NASDAQ: OFIX) is a leading global company specializing […]
LOS ANGELES , Aug. 29, 2024 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Orthofix Medical Inc. ("Orthofix" or the "Company") (NASDAQ: OFIX). Class Period:…
New York, New York--(Newsfile Corp. - August 28, 2024) - WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of Orthofix Medical Inc. (NASDAQ: OFIX) between October 11, 2022 and September 12, 2023, both dates inclusive (the "Class Period"). A class action lawsuit has already been filed. If you wish to serve Jetzt den vollständigen Artikel lesen
NEW YORK, Aug. 27, 2024 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of Orthofix Medical Inc. (NASDAQ: OFIX) between October 11, 2022 and September 12, 2023, both dates…
Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired Orthofix Medical Inc. (NASDAQ: OFIX) stock between October 11, 2022 and September 12, 2023. Orthofix is a global spine and orthopedics company that offers biologics, spinal hardware, bone growth therapies, and specialized orthopedic solutions, among other Jetzt den vollständigen Artikel lesen
New York, New York--(Newsfile Corp. - August 26, 2024) - WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of Orthofix Medical Inc. (NASDAQ: OFIX) between October 11, 2022 and September 12, 2023, both dates inclusive (the "Class Period"). A class action lawsuit has already been filed. If you wish to Jetzt den vollständigen Artikel lesen
Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming October 21, 2024 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Orthofix Medical Inc. (“Orthofix” or the “Company”) (NASDAQ: OFIX) common stock between October 11, 2022 and September 12, 2023, inclusive (the “Class Period”). If you Jetzt den vollständigen Artikel lesen
The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of persons and entities that purchased or otherwise acquired Orthofix Medical Inc. (“Orthofix” or the “Company”) (NASDAQ: OFIX) common stock between October 11, 2022 and September 12, 2023, inclusive (the “Class Period”). Orthofix investors have until October 21, 2024 to file a lead plaintiff Jetzt den vollständigen Artikel lesen
New York, New York--(Newsfile Corp. - August 25, 2024) - WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of Orthofix Medical Inc. (NASDAQ: OFIX) between October 11, 2022 and September 12, 2023, both dates inclusive (the "Class Period"). A class action lawsuit has already been filed. If you wish to serve Jetzt den vollständigen Artikel lesen